Potency: Evaluating Ghrelin Receptor Affinity in Ipamorelin and GHRP-6 Research Models Discover the key differences between Ipamorelin and GHRP-6, and learn how these powerful growth hormone secretagogues impact fat loss, anti-aging, sleep, and recovery
ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma
If training fasted (morning, before eating): Consume 10-15g essential amino acids or BCAAs 15 minutes before training Prioritize post-workout protein (30-40g within 30 minutes) Benefits: No nausea risk, enhanced fat oxidation Drawbacks: Potentially lower performance, increased muscle breakdown risk If training fed: Small meal 60-90 minutes pre-workout: 20-25g protein, 30-40g carbs Example: Rice cakes with almond butter and protein shake Benefits: Better performance, reduced muscle breakdown Drawbacks: Possible nausea if timing is poor Post-Workout Nutrition This is non-negotiable
Key Takeaways Cagrilintide is a long-acting amylin analogue with clinical trial doses ranging from 0.3 mg to 4.5 mg weekly, while retatrutide is a triple agonist studied at 4 mg, 8 mg, and 12 mg weekly doses No published clinical trials currently exist evaluating the cagrilintide dosage with retatrutide combination, making any combined use experimental and off-label Both peptides work through different mechanismscagrilintide activates amylin receptors while retatrutide targets GIP, GLP-1, and glucagon receptorssuggesting potential complementary effects Gastrointestinal side effects (nausea, vomiting) occur in 60-80% of participants at higher doses for both compounds, raising concerns about additive effects when combined Proper dose escalation protocols spanning 8-20 weeks are critical for tolerability and adherence in peptide-based metabolic therapies Understanding Cagrilintide: Mechanism and Dosage Fundamentals What Is Cagrilintide
Too-high levels of oxidative stress may be a precursor to multiple diseases
